Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Ephrins slow down skin and hair follicle cell growth.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Understanding EGFR roles could lead to new hair loss treatments.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Hair loss requires customized treatments based on its various causes and types.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

PRP treatment helped reverse hair thinning and promoted new hair growth.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

The review suggests seeing a dermatologist for scarring hair loss and using treatments like minoxidil or finasteride for common male and female pattern hair loss.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

The document concludes that hair loss has many causes and treatments vary, including medication for pattern baldness and addressing underlying issues for other types.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.